Anti-PTPRH monoclonal antibody

Pre-made anti-PTPRH monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to PTPRH/PTPRH products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1459-Ab-1/ GM-Tg-hg-IP1459-Ab-2Anti-Human PTPRH monoclonal antibodyHuman
GM-Tg-rg-IP1459-Ab-1/ GM-Tg-rg-IP1459-Ab-2Anti-Rat PTPRH monoclonal antibodyRat
GM-Tg-mg-IP1459-Ab-1/ GM-Tg-mg-IP1459-Ab-2Anti-Mouse PTPRH monoclonal antibodyMouse
GM-Tg-cynog-IP1459-Ab-1/ GM-Tg-cynog-IP1459-Ab-2Anti-Cynomolgus/ Rhesus macaque PTPRH monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1459-Ab-1/ GM-Tg-felg-IP1459-Ab-2Anti-Feline PTPRH monoclonal antibodyFeline
GM-Tg-cang-IP1459-Ab-1/ GM-Tg-cang-IP1459-Ab-2Anti-Canine PTPRH monoclonal antibodyCanine
GM-Tg-bovg-IP1459-Ab-1/ GM-Tg-bovg-IP1459-Ab-2Anti-Bovine PTPRH monoclonal antibodyBovine
GM-Tg-equg-IP1459-Ab-1/ GM-Tg-equg-IP1459-Ab-2Anti-Equine PTPRH monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1459-Ab-1/ GM-Tg-hg-IP1459-Ab-2; GM-Tg-rg-IP1459-Ab-1/ GM-Tg-rg-IP1459-Ab-2;
GM-Tg-mg-IP1459-Ab-1/ GM-Tg-mg-IP1459-Ab-2; GM-Tg-cynog-IP1459-Ab-1/ GM-Tg-cynog-IP1459-Ab-2;
GM-Tg-felg-IP1459-Ab-1/ GM-Tg-felg-IP1459-Ab-2; GM-Tg-cang-IP1459-Ab-1/ GM-Tg-cang-IP1459-Ab-2;
GM-Tg-bovg-IP1459-Ab-1/ GM-Tg-bovg-IP1459-Ab-2; GM-Tg-equg-IP1459-Ab-1/ GM-Tg-equg-IP1459-Ab-2
Products NameAnti-PTPRH monoclonal antibody
Formatmab
Target NamePTPRH
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-PTPRH monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1459-Ag-1Recombinant multi-species PTPRH/ R-PTP-H/ SAP1 protein


    Target information

    Target IDGM-IP1459
    Target NamePTPRH
    Gene ID5794,545902,171125,699032,484299,101092313,521868,100055444
    Gene Symbol and SynonymsBem2,PTPRH,R-PTP-H,sap-1,SAP1
    Uniprot AccessionQ9HD43
    Uniprot Entry NamePTPRH_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000080031
    Target ClassificationN/A

    The target: PTPRH, gene name: PTPRH, also named as R-PTP-H, SAP1. The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP possesses an extracellular region, a single transmembrane region, and a single intracytoplasmic catalytic domain, and thus represents a receptor-type PTP. The extracellular region contains eight fibronectin type III-like repeats and multiple N-glycosylation sites. The gene was shown to be expressed primarily in brain and liver, and at a lower level in heart and stomach. It was also found to be expressed in several cancer cell lines, but not in the corresponding normal tissues. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.